Co-Authors
This is a "connection" page, showing publications co-authored by ANDREW DINARDO and TARA NESS.
Connection Strength
1.868
-
Optimizing DNA Extraction from Pediatric Stool for Diagnosis of Tuberculosis and Use in Next-Generation Sequencing Applications. Microbiol Spectr. 2023 02 14; 11(1):e0226922.
Score: 0.838
-
Rapid Diagnostic Sequencing of Stool DNA Using Targeted Nanopore Sequencing in Patients With a Pulmonary Tuberculosis Diagnosis. Open Forum Infect Dis. 2025 Apr; 12(4):ofaf121.
Score: 0.245
-
Targeted therapeutic drug monitoring identifies frequent under-dosing of TB drugs. Int J Tuberc Lung Dis. 2025 Jan 01; 29(1):41-43.
Score: 0.242
-
High Throughput Sequencing for Clinical Tuberculosis: An Overview. Pathogens. 2022 Nov 14; 11(11).
Score: 0.209
-
Performance of a novel stool quantitative polymerase chain reaction assay for pediatric tuberculosis detection in sub-Saharan Africa. J Pediatric Infect Dis Soc. 2025 May 20.
Score: 0.062
-
Drug susceptibility testing for TB using the Xpert MTB/XDR assay on stool specimens. Int J Tuberc Lung Dis. 2025 Mar 31; 29(4):189-192.
Score: 0.061
-
Performance of a stool-based quantitative PCR assay for the diagnosis of tuberculosis in adolescents and adults: a multinational, prospective diagnostic accuracy study. Lancet Microbe. 2024 May; 5(5):e433-e441.
Score: 0.057
-
Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis. Clin Infect Dis. 2023 01 06; 76(1):10-17.
Score: 0.053
-
Correction: Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 Sep 20; 14(1):107.
Score: 0.052
-
Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 05 19; 14(1):52.
Score: 0.050